Birth Asphyxia Clinical Trial
Official title:
Augmented Infant Resuscitator (AIR): Transitioning a Novel Behavior Change Innovation to Drive Newborn Ventilation Skills Enhancement
Verified date | March 2023 |
Source | Massachusetts General Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Augmented Infant Resuscitator (AIR) is an inexpensive add-on, compatible with nearly every existing bag-valve mask and many types of ventilation equipment. AIR monitors ventilation quality and provides real-time objective feedback and actionable cues to clinicians to both shorten training times and improve resuscitation quality, adoption, retention, and confidence.
Status | Active, not recruiting |
Enrollment | 250 |
Est. completion date | June 30, 2024 |
Est. primary completion date | June 30, 2024 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Skilled birth attendants (SBAs) working clinically at the selected facilities (i.e., in-service providers) - SBAs who participate in the HBB training offered by our group at the beginning of the study - SBAs who demonstrate competence, after initial training, in key neonatal resuscitation skills and competencies (i.e., pass the BMV skills check and OSCE B) - SBAs able to adequately understand the language in which the HBB training is offered (e.g., the investigators anticipate the trainings will be offered in English) - SBAs over 18 years of age - SBAs who provide written informed consent for participation in the study Exclusion Criteria: - Students or clinicians still in training (i.e., pre-service providers) - SBAs and other health workers who do not participate in initial HBB training - SBAs that are unable to adequately understand the language in which the HBB training is offered - SBAs under 18 years of age - SBAs who do not provide written informed consent for participation in the study |
Country | Name | City | State |
---|---|---|---|
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Massachusetts General Hospital | Grand Challenges Canada, United States Agency for International Development (USAID) |
United States,
Ali A, Nudel J, Heberle CR, Santorino D, Olson KR, Hur C. Cost effectiveness of a novel device for improving resuscitation of apneic newborns. BMC Pediatr. 2020 Jan 30;20(1):46. doi: 10.1186/s12887-020-1925-5. — View Citation
Bennett DJ, Itagaki T, Chenelle CT, Bittner EA, Kacmarek RM. Evaluation of the Augmented Infant Resuscitator: A Monitoring Device for Neonatal Bag-Valve-Mask Resuscitation. Anesth Analg. 2018 Mar;126(3):947-955. doi: 10.1213/ANE.0000000000002432. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Effective bag-mask ventilation | Duration of effective bag-mask ventilation by clinician during a 2-minute trial. This is measured internally from the AIR device. "Effective ventilation" is defined as having all three of the following conditions simultaneously: (1) Correct rate (30-60 breaths per minute); (2) Absence of significant leak (compliance >4.0mL/cm H2O); and (3) Absence of a significant airway blockage (defined as compliance <0.10 mL/cm H2O or resistance >90 cmH2O/L/s). These measurements are determined by sensors in the AIR device for all arms of the study. Their accuracy for manikin use was determined to be 100% in the following trial: Bennett el al. Anesth Analgesia. 2018 Mar;126(3):947-955. doi: 10.1213/ANE.0000000000002432. | 2 minutes | |
Primary | Time to effective bag-mask ventilation | How long it takes for clinician to achieve effective ventilation during 2-minute trial -- timed from when the mask first touches the face of the manikin until all three icons are green. This is measured by an observer using a stop-watch. Again, "effective ventilation" is defined as having all three of the following conditions simultaneously and is indicated to the RA by all three icons on the AIR device turning green: (1) Correct rate (30-60 breaths per minute); (2) Absence of significant leak (compliance >4.0mL/cm H2O); and (3) Absence of a significant airway blockage (defined as compliance <0.10 mL/cm H2O or resistance >90 cmH2O/L/s). | 2 minutes | |
Primary | Bag-mask ventilation skills immediately after training | Clinicians' bag-mask ventilation skills will be assessed immediately after training. Assessment of these skills will be done using current standards, namely the HBB program's 'Bag-mask ventilation skills test' and 'OSCE B.' | Immediately after training | |
Primary | Bag-mask ventilation skills 2 months post-training | Clinicians' bag-mask ventilation skills will be assessed 2 months after training. Assessment of these skills will be done using current standards, namely the HBB program's 'Bag-mask ventilation skills test' and 'OSCE B.' | 2 months after training | |
Primary | Bag-mask ventilation skills 4 months post-training | Clinicians' bag-mask ventilation skills will be assessed 4 months after training. Assessment of these skills will be done using current standards, namely the HBB program's 'Bag-mask ventilation skills test' and 'OSCE B.' | 4 months after training | |
Primary | Bag-mask ventilation skills 6 months post-training | Clinicians' bag-mask ventilation skills will be assessed 6 months after training. Assessment of these skills will be done using current standards, namely the HBB program's 'Bag-mask ventilation skills test' and 'OSCE B.' | 6 months after training | |
Secondary | Provider-level perceptions - focus groups | Provider perceptions of the AIR device, using focus group discussions. | 6 months | |
Secondary | Provider-level perceptions - interviews | Provider perceptions of the AIR device, using semi-structured interviews. | 6 months | |
Secondary | Cost analysis | Cost analysis for implementation and evaluation of the AIR device | 6 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01913340 -
Neonatal Erythropoietin And Therapeutic Hypothermia Outcomes in Newborn Brain Injury (NEATO)
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT04169191 -
Sildenafil to Repair Brain Injury Secondary to Birth Asphyxia
|
Phase 1 | |
Completed |
NCT02858583 -
SI + CC Versus 3:1 C:V Ratio During Neonatal CPR
|
N/A | |
Recruiting |
NCT03657394 -
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries
|
N/A | |
Recruiting |
NCT03682042 -
Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries Developmental Follow Up
|
N/A | |
Withdrawn |
NCT03681314 -
Umbilical Cord Milking in Neonates Who Are Depressed at Birth-Developmental Follow Up (MIDAB-FU)
|
N/A | |
Completed |
NCT02862925 -
Introducing Fetal Scalp Stimulation as an Adjunct to Intermittent Auscultation in Low-Resource Settings.
|
N/A | |
Completed |
NCT01751945 -
Improved Accessibility of EmONC Services for Maternal and Newborn Health: a Community Based Project
|
N/A | |
Terminated |
NCT03885492 -
The Baby-Saver Kit: Clinical Testing of a Device for Neonatal Resuscitation With Intact Cord in Uganda
|
||
Completed |
NCT01743742 -
First-day High Dose Vitamin C, E in Severe Birth Asphyxia
|
Phase 4 | |
Completed |
NCT05946681 -
Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings
|
||
Recruiting |
NCT03577054 -
Development of a Mobile Application for HBB Prompt Study
|
N/A | |
Active, not recruiting |
NCT05854745 -
Comparison of Virtual Training to In-Person Training of Helping Babies Breathe in Ethiopia
|
N/A | |
Not yet recruiting |
NCT05707962 -
Neuroprotective Efficacy of Postnatal Magnesium Sulphate in Term Infants With Birth Asphyxia
|
N/A | |
Completed |
NCT01869582 -
Safer Births - Reducing Perinatal Mortality
|
N/A | |
Completed |
NCT01350765 -
Naushero Feroze Neonatal Survival Project
|
N/A | |
Recruiting |
NCT04043299 -
Effect of Intrapartum Oxygen Administration on Fetal and Early Neonatal Outcomes
|
Phase 3 | |
Completed |
NCT01865656 -
A Skills and Drills Intervention for Emergency Obstetrics and Neonatal Care at First Referral Units of North Karnataka
|
N/A | |
Active, not recruiting |
NCT04714502 -
Asphyxia Associated Metabolite Biomarker Investigation 2
|
||
Recruiting |
NCT05275725 -
Finding Solutions to Thrive After Birth Asphyxia in Africa
|
Phase 1 |